Proton Pump Inhibitors and Risk of Dementia: A Hypothesis Generated but Not Adequately Tested

Area of Science:

• Geriatric Medicine
• Pharmacology
• Epidemiology

Background:

• Proton pump inhibitors (PPIs) are globally prevalent medications.
• Dementia impacts approximately 5% of individuals aged 60 and older worldwide.
• Existing research presents plausible biological mechanisms linking PPIs and dementia, but epidemiological data remains inconclusive.

Purpose of the Study:

• To review and synthesize the current evidence regarding the association between proton pump inhibitor (PPI) use and dementia.
• To assess the implications of existing research for clinical practice and public health policy.

Main Methods:

• Comprehensive review of available scientific literature, including basic research, epidemiological studies (descriptive and analytic), and randomized controlled trials.
• Evaluation of the consistency and strength of evidence from various study designs.

Main Results:

• Basic science research suggests potential mechanisms linking PPIs to dementia.
• Epidemiological studies have not shown consistent evidence of an association.
• A significant large-scale randomized trial found no association between PPI use and dementia.

Conclusions:

• The current body of evidence provides more reassurance than cause for alarm regarding PPIs and dementia.
• Uncertainty persists due to incomplete evidence, necessitating further large-scale randomized trials.
• Informed clinical and public health decisions require more robust, conclusive data.